TXNRD3IT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.889000E-01
Normal-vs-Stage2
9.352400E-01
Normal-vs-Stage3
6.608200E-01
Normal-vs-Stage4
8.987200E-01
Stage1-vs-Stage2
8.902200E-01
Stage1-vs-Stage3
3.817000E-01
Stage1-vs-Stage4
8.745400E-01
Stage2-vs-Stage3
4.634600E-01
Stage2-vs-Stage4
8.307000E-01
Stage3-vs-Stage4
6.013400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.140600E-01
Normal-vs-AfricanAmerican
9.900400E-01
Normal-vs-Asian
8.894800E-01
Caucasian-vs-AfricanAmerican
9.019400E-01
Caucasian-vs-Asian
9.717400E-01
AfricanAmerican-vs-Asian
8.882800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.834000E-01
Normal-vs-Female
9.148400E-01
Male-vs-Female
1.394580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.570400E-01
Normal-vs-Age(41-60Yrs)
8.941000E-01
Normal-vs-Age(61-80Yrs)
7.407600E-01
Normal-vs-Age(81-100Yrs)
6.843000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.592600E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.256300E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.194100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.007600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.022200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.119800E-01
Normal-vs-Daily Drinker
7.872400E-01
Normal-vs-Weekly Drinker
7.036400E-01
Normal-vs-Occasional Drinker
7.854600E-01
Normal-vs-Social Drinker
8.185200E-01
Non Drinker-vs-Daily Drinker
8.282800E-01
Non Drinker-vs-Weekly Drinker
4.081000E-01
Non Drinker-vs-Occasional Drinker
8.017400E-01
Non Drinker-vs-Social Drinker
5.214600E-01
Daily Drinker-vs-Weekly Drinker
1.893810E-01
Daily Drinker-vs-Occasional Drinker
9.336400E-01
Daily Drinker-vs-Social Drinker
3.160200E-01
Weekly Drinker-vs-Occasional Drinker
2.187400E-01
Weekly Drinker-vs-Social Drinker
8.477200E-01
Occasional Drinker-vs-Social Drinker
3.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.993000E-01
Normal-vs-Grade 2
7.830500E-02
Normal-vs-Grade 3
1.542030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.783180E-04
Grade 1-vs-Grade 3
4.47880000000733E-05
Grade 1-vs-Grade 4
3.993000E-01
Grade 2-vs-Grade 3
9.882200E-02
Grade 2-vs-Grade 4
7.830500E-02
Grade 3-vs-Grade 4
1.542030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.087000E-01
Normal-vs-NonDiabetic
9.439400E-01
Diabetic-vs-NonDiabetic
3.189800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.584800E-01
Normal-vs-NoPancreatitis
8.740000E-01
Pancreatitis-vs-NoPancreatitis
1.487170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.003400E-01
Normal-vs-N1
9.982000E-01
N0-vs-N1
3.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.602800E-01
Normal-vs-TP53-NonMutant
9.219200E-01
TP53-Mutant-vs-TP53-NonMutant
1.271860E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
